A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

NCT00847613 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: Placebo
DRUG: CP-690,550
DRUG: Placebo
DRUG: CP-690,550

Sponsor

Pfizer